ATE444946T1 - Verzweigte carbonsäureverbindung und deren verwendung - Google Patents

Verzweigte carbonsäureverbindung und deren verwendung

Info

Publication number
ATE444946T1
ATE444946T1 AT04747782T AT04747782T ATE444946T1 AT E444946 T1 ATE444946 T1 AT E444946T1 AT 04747782 T AT04747782 T AT 04747782T AT 04747782 T AT04747782 T AT 04747782T AT E444946 T1 ATE444946 T1 AT E444946T1
Authority
AT
Austria
Prior art keywords
carboxylic acid
parkinson
integer
disease
acid compound
Prior art date
Application number
AT04747782T
Other languages
English (en)
Inventor
Haruo Imawaka
Tomoyuki Hasegawa
Shigeru Sakuyama
Yasufumi Kawanaka
Tsutomu Akiyama
Masamitsu Hoshikawa
Saiko Matsuda
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE444946T1 publication Critical patent/ATE444946T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
AT04747782T 2003-07-15 2004-07-14 Verzweigte carbonsäureverbindung und deren verwendung ATE444946T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003274988 2003-07-15
PCT/JP2004/010366 WO2005005366A1 (ja) 2003-07-15 2004-07-14 分枝鎖カルボン酸化合物およびその用途

Publications (1)

Publication Number Publication Date
ATE444946T1 true ATE444946T1 (de) 2009-10-15

Family

ID=34056106

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04747782T ATE444946T1 (de) 2003-07-15 2004-07-14 Verzweigte carbonsäureverbindung und deren verwendung

Country Status (6)

Country Link
US (1) US7579375B2 (de)
EP (1) EP1650182B1 (de)
JP (1) JP4788999B2 (de)
AT (1) ATE444946T1 (de)
DE (1) DE602004023510D1 (de)
WO (1) WO2005005366A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
HRP20140240T4 (hr) 2005-11-30 2017-02-24 Abbvie Inc. Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
EP3533803B1 (de) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antikörper
US8921533B2 (en) 2011-07-25 2014-12-30 Chromatin Technologies Glycosylated valproic acid analogs and uses thereof
WO2013024028A1 (en) * 2011-08-12 2013-02-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compounds and compositions for treating proteinopathies
KR101890058B1 (ko) * 2017-02-21 2018-08-21 동국대학교 산학협력단 신규한 마리올라이드 유도체 및 이를 함유하는 만성 염증성 질환의 예방 또는 치료용 조성물
WO2020214960A1 (en) * 2019-04-18 2020-10-22 Prevep Llc Therapeutic combinations, liquid pharmaceutical compositions, kits for their preparation, and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604182A (ja) 1983-06-22 1985-01-10 Yamanouchi Pharmaceut Co Ltd ピリミドン誘導体及びその製法
DE3617177A1 (de) * 1986-05-22 1987-11-26 Basf Ag Verfahren zur herstellung von (alpha)-substituierten (gamma)-butyrolactonen
JPH04279576A (ja) 1991-03-07 1992-10-05 Tanabe Seiyaku Co Ltd 光学活性４−ペンタノライド誘導体の製法
EP0632008B1 (de) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentansäurederivate
WO2003007992A1 (en) 2001-07-18 2003-01-30 Ono Pharmaceutical Co., Ltd. Remedies for brain ischemic diseases

Also Published As

Publication number Publication date
JP4788999B2 (ja) 2011-10-05
JPWO2005005366A1 (ja) 2006-08-24
US7579375B2 (en) 2009-08-25
WO2005005366A1 (ja) 2005-01-20
EP1650182A4 (de) 2006-10-11
US20070167522A1 (en) 2007-07-19
EP1650182B1 (de) 2009-10-07
EP1650182A1 (de) 2006-04-26
DE602004023510D1 (de) 2009-11-19

Similar Documents

Publication Publication Date Title
WO2004020431A3 (en) Novel benzoimidazole derivatives useful as antiproliferative agents
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
DE602005004286D1 (de) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyridoä2,3-düpyrimidinderivate und verwandte verbindungen zur behandlung von krebs
UA83899C2 (uk) Сполуки імідазолу для лікування нейродегенеративних розладів
IL214852A0 (en) N-substituted-4-heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain and pharmaceutical composition comprising the same
IL195378A0 (en) Radioactive substituted heterocycle derivative and diagnostic agent for alzheimer's containing it
MXPA04000411A (es) Tiazolidinonas arilo sustituidas y uso de las mismas.
IL189762A0 (en) Isoxazolo derivatives as gaba a alpha5 inverse agonists
ATE444946T1 (de) Verzweigte carbonsäureverbindung und deren verwendung
IL191935A (en) The water-soluble benzozepine compound @ and its @pharmaceutical @ preparation
PL2017276T3 (pl) Związki fenylowo-karboksamidowe przydatne do leczenia bólu
IL190867A0 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
SG161217A1 (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
PT2420491E (pt) Compostos de piperidina 3,5-substituída como inibidores de renina
TW200745135A (en) Therapeutic agents
MX2009014001A (es) Derivados de isoxazol-imidazol.
IL194889A0 (en) Compound having affinity to amyloid
TW200736251A (en) Aryl-isoxazol-4-yl-imidazole derivatives
EP2127650A3 (de) Antibakterielle Carbapenem-Mittel mit gram-negativer Wirkung und Herstellungsverfahren dafür
TW200602297A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
TW200745033A (en) Oxindole derivative as feeding control agent
EP1958939A3 (de) Pyrazolaminverbindungen zur Behandlung neurodegenerativer Erkrankungen
DE69822937D1 (de) Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen
IL184439A0 (en) 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1
WO2006031719A3 (en) 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties